Hottest Stocks (Over $10)	Hottest Stocks ($2-$10)	Biggest Losers (Over $10)	Biggest Losers ($2-$10)	Hottest Industries	Hottest Sectors	EPS / Sales Surprises
Enter Ticker Symbol:   Ticker Lookup Company Quote Company Profile Research Summary EPS Consensus Perspective Insider Transactions Price Performance

Enter any portion of the company’s name to find its corresponding ticker symbol:

Search for :

Zacks Company Profile for Embecta Corp. (EMBC : NSDQ)

• Company Description    Embecta Corp. is a pure-play diabetes care company. Embecta is based in FRANKLIN LAKES, N.J. Number of Employees: 1,850

• Price / Volume Information    Yesterday's Closing Price: $11.88 Daily Weekly Monthly 20 Day Moving Average: 686,054 shares Shares Outstanding: 59.21 (millions) Market Capitalization: $703.44 (millions) Beta: 1.11 52 Week High: $21.23 52 Week Low: $9.20 Short Interest Ratio:   % Price Change % Price Change Relative to S&P 500 4 Week 1.71% 1.88% 12 Week -12.58% -13.99% Year To Date 0.00% 0.00%

• Address & Contact Information Street Address Phone / Fax Email Address Web URL 300 Kimball Drive - Parsippany,NJ 07054 USA ph: 862-401-0000 fax: - investor.relations@embecta.com http://www.embecta.com

• General Corporate Information    Officers Devdatt Kurdikar - President and Chief Executive Officer David F. Melcher - Chairman of the Board and Director Jacob Elguicze - Senior Vice President; Chief Financial Officer Carrie L. Anderson - Director Claire Pomeroy - Director Peer Information Embecta Corp. (CHCR) Embecta Corp. (ESRX) Embecta Corp. (MYDP) Embecta Corp. (COR) Embecta Corp. (GBCS) Embecta Corp. (LAXAF) Industry / Sector / Ticker Info Analyst Coverage: No Industry Group: Medical Services Sector: Medical CUSIP: 29082K105 SIC: 3841 Fiscal Year Fiscal Year End: September Last Reported Quarter: 09/01/25 Next Expected EPS Date: 02/05/26 Share - Related Items Shares Outstanding: 59.21 Most Recent Split Date: (:1) Beta: 1.11 Market Capitalization: $703.44 (millions)

• EPS Information     • Dividend Information Analyst Coverage: No Dividend Yield: 5.05% Current Fiscal Quarter EPS Consensus Estimate: $0.67 Indicated Annual Dividend: $0.60 Current Fiscal Year EPS Consensus Estimate: $2.90 Payout Ratio: 0.20 Number of Estimates in the Fiscal Year Consensus: 1.00 Change In Payout Ratio: -0.02 Estmated Long-Term EPS Growth Rate: % Last Dividend Paid: 12/05/2025 - $0.15 Next EPS Report Date: 02/05/26

• Fundamental Ratios P/E Current FY Estimate: 4.10 Trailing 12 Months: 4.00 PEG Ratio: - Price Ratios Price/Book: - Price/Cash Flow: 2.97 Price / Sales: 0.65 EPS Growth vs. Year Ago Period: 11.11% vs. Previous Quarter: -55.36% Sales Growth vs. Year Ago Period: -7.72% vs. Previous Quarter: -10.66% ROE 12/31/25 - - 09/30/25 - -24.62 06/30/25 - -23.40 ROA 12/31/25 - - 09/30/25 - 15.40 06/30/25 - 14.46 Current Ratio 12/31/25 - - 09/30/25 - 2.41 06/30/25 - 2.47 Quick Ratio 12/31/25 - - 09/30/25 - 1.73 06/30/25 - 1.78 Operating Margin 12/31/25 - - 09/30/25 - 16.10 06/30/25 - 15.46 Net Margin 12/31/25 - - 09/30/25 - 8.83 06/30/25 - 7.58 Pre-Tax Margin 12/31/25 - - 09/30/25 - 12.62 06/30/25 - 9.10 Book Value 12/31/25 - - 09/30/25 - -11.12 06/30/25 - -11.46 Inventory Turnover 12/31/25 - - 09/30/25 - 2.28 06/30/25 - 2.35 Debt-to-Equity 12/31/25 - - 09/30/25 - - 06/30/25 - - Debt-to-Capital 12/31/25 - - 09/30/25 - - 06/30/25 - -

Powered by Zacks Investment Research ©